The use of TDM data to assess the validity of defined daily doses of antiepileptics: A comparison between a Czech and Swedish University Hospital

Therapeutic Drug Monitoring

Volumn 28, Issue 5, 2006, Pages 589-593

  Koristkova, Blanka ^a   Sjöqvist, Folke ^b   Grundmann, Milan ^a   Bergman, Ulf ^b  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiepileptics; Defined daily dose; Drug utilization; TDM

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CZECH REPUBLIC; DOSE RESPONSE; DRUG MONITORING; EPILEPSY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; OUTPATIENT; PRIORITY JOURNAL; QUALITY CONTROL; SWEDEN; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CZECH REPUBLIC; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG UTILIZATION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; SWEDEN;

EID: 33749850063     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000245383.79939.ed     Document Type: Article

References (17)

1. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 8th ed. Oslo, Norway. Available at: www.whocc.no; 2005.
2. Bergman U, Rane A, Sjöqvist F, et al. Digoxin and phenytoin analyses as part of consultations in clinical pharmacology: a study on the use of drugs. Ther Drug Monit. 1981;3:259-269.
3. Brozmanova H, Grundmann M. First experiences with therapeutic monitoring of antiepileptics. Cesk Fysiol. 1985;34:416 [in Czech].
4. WHO Collaborating Centre for Drug Statistics Methodolology web site, ATC index 2005, valid from January 2005. Available at: www.whocc/atcddd; Accessed on: January 21, 2005.
5. Koristkova B, Bergman U, Brozmanova H, et al. Therapeutic drug monitoring of antiepileptic drugs: Comparison between a Czech and a Swedish University Hospital. Ther Drug Monit. 2006;28:594-598.
6. FASS (Pharmaceutical specialities in Sweden), LINFO Lä kemedelsinformation AB, Stockholm, Sweden; 1999.
7. Medistranky, MediMedia Information s.r.o, Praha, Czech Republic; 2004.
8. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. 1st ed. Oslo, Norway; 1996.
9. Rochat P, Hallas J, Gaist D, et al. Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol Scand. 2001;104:6-11.
10. Shackleton DP, Westendorp RGJ, Kasteleijn-Nolst Trenité DGA, et al. Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures. J Clin Epidemiol. 1997;50:1061-1068.
11. Peytchev L, Atansova I, Terziivanov D. Antiepileptic drug utilization in outpatients - A prescribing pattern study. Int J Clin Pharmacol Ther. 1996;34:444-445.
12. Lammers MW, Hekster YA, Keyser A, et al. Use of antiepileptic drugs in a community-dwelling Dutch population. Neurology. 1996;46:62-67.
13. Roberts SJ, Feely M, Bateman DN. Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992-1995. Seizure. 1998;7:127-132.
14. Koristkova B, Grundmann M. Consumption of antiepileptics in 1993-2004 using various methods. Ceska Slov Farm. 2006;55:18-23 [In Czech].
15. Böttiger Y, Svensson JO, Ståhle L. Lamotrigine drug interactions in a TDM material. Ther Drug Monit. 1999;21:171-174.
16. Yasar Ü, Blomgren K, Persson M, et al. Hepatic and haematological adverse reactions of lamotrigine in Sweden. Eur J of Clin Pharm. 2001;57:10A.
17. Koristkova B, Grundmann M. The differences between prescribed daily doses and defined daily doses of AEDs. Therapeutic drug monitoring as a marker of the quality of the treatment. Int J Clin Pharmacol. 2006;44:438-442.